Inhibitors | Comment | Organism | Structure |
---|---|---|---|
pefabloc | - |
Sus scrofa | |
ulinastatin | - |
Sus scrofa |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Sus scrofa | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
pancreas | - |
Sus scrofa | - |
pancreatic acinar cell | - |
Sus scrofa | - |
pancreatic islet | - |
Sus scrofa | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
N-benzoyl-L-arginine ethyl ester + H2O | - |
Sus scrofa | N-benzoyl-L-arginine + ethanol | - |
? |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
25 | - |
assay at | Sus scrofa |
General Information | Comment | Organism |
---|---|---|
malfunction | trypsin from pancreatic acinar cells destroys islets. Thus pancreatic slet transplantation which has emerged as an effective therapy and potential cure for type 1 diabetes mellitus, requires inhibition of trypsin activity by ulinastatin or pefabloc, optimization of islet preservation using the two-layer method, TLM, overview | Sus scrofa |